WIHRA advocates for the use of standard-dose naloxone (4mg nasal spray or lower) and actively rejects the claims that higher doses are necessary or more effective. This echoes the response of harm reduction advocates nationwide and that of the Wisconsin Department of Health Services. Read more about the importance of using standard-dose naloxone below.